Skip to main content
Clinical Trials/TCTR20240728001
TCTR20240728001
Completed
Phase 3

Anti-inflammatory effect of platelet-rich plasma compared with Intraarticular corticosteroid in 2 osteoarthritis knee: A randomized controlled trial

Department of orthopedic, Phramongkutklao hospital0 sites80 target enrollmentJuly 28, 2024

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of orthopedic, Phramongkutklao hospital
Enrollment
80
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 28, 2024
End Date
May 30, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of orthopedic, Phramongkutklao hospital

Eligibility Criteria

Inclusion Criteria

  • Patients who had been diagnosed as osteoarthritis knee according to American college of rheumatology

Exclusion Criteria

  • secondary osteoarthritis knee, inflammatory joint disease, previous knee infection, or previous knee surgery, high risk for injection treatment such as immunocompromised host, on anticoagulants, hemophilia or other bleeding disorders; and susceptibility to platelet dysfunction such as antiplatelet drugs use, low platelet count(\<150,000/mm3\), or autoimmune disorders

Outcomes

Primary Outcomes

Not specified

Similar Trials